Market Research Logo

Ireland Pharmaceuticals & Healthcare Q4 2018

Ireland Pharmaceuticals & Healthcare Q4 2018

Key View:

Despite the improved outlook for pharmaceutical consumption rates relative to the previous five years, Ireland’s smallmarket size by regional standards, together with cost control measures targeting the sector, will continue to limit the country’sattractiveness to drugmakers. We highlight upside risks to our forecasts dependent upon the success of the implementation of thehealth system reform. More broadly, the significant dependence of the Irish economy on a limited number of large multinationalsposes risks to overall market trends under an uncertain global trade environment. On the upside, the increasing prospect a'soft' Brexit bodes well for the Irish economy, supporting our sector market growth headlines.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Ireland Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Ireland Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report